Team:Aix-Marseille/Model

Engineered M13 modelling


In order to produce PLPs, both M13KO7 (produces all the phage proteins) and the phagemid (containing the toxin gene) need to be integrated into E.coli. During the process, if p5 packages M13KO7 it will produce a replicative phage and if it packages our phagemid it will produce PLPs.

With our project, KILL XYL we set to engineer a cure against the disease caused by the plant pathogen Xylella fastidiosa. One of our approaches is to engineer phage-like particles (PLPs), that will deliver toxic genes into the bacterium. Phage systems, like M13, have been employed in biotechnological applications, most prominently in the identification and maturation of medically-relevant binding molecules through phage display [1].

However, production of phages such as M13 has longterm consequences in E. coli, especially regarding metabolism[2]. M13 has a particular life-cycle among phages: it is neither a virulent nor a temperate phage but rather engages in chronic infection. One of the crucial events of it's multiplication is the packaging of its own DNA in the capsid. To do so, M13's protein 5 (p5) targets M13 origin of replication (M13ori) and packages the single-strand DNA. This step is crucial to initiate formation of the phage particle. Afterwards, an assembly complex (made of proteins p1, p4 and p11) assembles the capsid (made of proteins p3, p6, p7, p8, p9) around the ssDNA.

One of the major reasons we chose to use phage-like particles (PLPs) was for our device to be non replicative, so as to prevent the spread of GMOs in the environnement. We designed these PLPs by modifying M13's genome to prevent replication and the addition of a phagemid in the factory cell E.coli. Therefore, to create PLPs we use a modified M13 genome (M13KO7) that has several genes inserts in it M13ori and we integrate a phagemid with a M13ori.

Thanks to Jacques VAN HELDEN interview we put attention to the risk of recombination between M13KO7 and the phagemid. This question matter because we aim to create PLPs that aren't able to replicate and thus spread in the environment. Therefore, we test this possibility along our wetlab tests.

Here we wanted to answer a single question: As p5 recognized M13ori, will the bacterium produces only PLPs or will it also produces replicative phages ?.

First iteration of the model

We started with an excessively simple model to see whether our understanding of our system was profound enough to allow room for such simplifications. We made the following assumptions in this spirit:

Which led to the following model:

Assumption Reasonning
Neglecting cooperative effects
Constant rate of p5 transcription/traduction
One M13KO7 per factory cell
Phage assembly isn't a limiting factor
Neglecting stochasticity


Second iteration

This time, we decided to adopt the model of a "wild-type" M13's biology [2][3] to fit our own engineered version of M13 and better inform wet lab experiments, as well as explain some of their preliminary findings!

Model validation

compare particle profile to that obtained in wet lab

--> Insufficient p3

could cause the packing of several DNA molecules per phage.

What is the ideal number of plasmid copies

Wet-lab and dry-lab back and forth

References

  1. ↑ Salmond, G. P. C. & Fineran, P. C. A century of the phage: past, present and future. Nat Rev Micro 13, 777–786 (2015).
  2. ↑ 2.0 2.1 Smeal et al, Simulation of the M13 life cycle I: Assembly of a genetically-structured deterministic chemical kinetic simulation, Virology, 500, January 2017
  3. ↑ Smeal et al, Simulation of the M13 life cycle II: Investigation of the control mechanisms of M13 infection and establishment of the carrier state, Virology, 500, January 2017